Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Apollo Endosurgery Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
76.86M 71.71M 68.49M 65.79M 62.99M 59.68M 56.15M 45.19M
Cost of Revenue
34.43M 31.54M 29.83M 28.97M 28.03M 26.63M 25.35M 21.07M
Gross Profit
42.43M 40.17M 38.66M 36.83M 34.96M 33.05M 30.81M 24.11M
Operating Income
-27.82M -26.3M -24.51M -23.17M -19.68M -16.75M -13.82M -12.87M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-39.26M -40.35M -35.64M -28.21M -24.53M -17.51M -13.5M -16.8M
Net Income
-39.84M -40.69M -35.9M -28.5M -24.68M -17.78M -13.72M -16.96M
Selling & General & Admin
56.59M 53.26M 50.18M 47.35M 42.76M 38.67M 34.53M 27.61M
Research & Development
11.91M 10.91M 10.68M 10.31M 9.52M 9.23M 8.19M 7.45M
Other Expenses
1.75M 1.82M 1.84M 1.86M 1.88M 1.89M 1.91M 1.93M
Operating Expenses
70.25M 65.99M 62.69M 59.52M 54.16M 49.79M 44.62M 36.98M
Interest Expense
4.67M 7.87M 8.06M 8.19M 8.32M 5.38M 5.38M 5.36M
Selling & Marketing Expenses
36.01M 33.33M 30.86M 27.74M 24.31M 21.5M 19.55M 15.81M
Cost & Expenses
104.68M 97.53M 92.52M 88.49M 82.19M 76.42M 69.97M 58.06M
Income Tax Expense
584K 344K 262K 284K 156K 272K 223K 158K
Shares Outstanding (Basic)
30.24M 40.85M 40.36M 39.65M 38.26M 29.02M 27.27M 26.31M
Shares Outstanding (Diluted)
30.24M 40.85M 40.36M 39.65M 38.26M 29.02M 27.27M 26.31M
EPS (Basic)
-1.07 -1.02 -0.97 -0.82 -0.78 -0.64 -0.52 -0.71
EPS (Diluted)
-1.07 -1.02 -0.97 -0.82 -0.78 -0.64 -0.52 -0.71
EBITDA
-28.41M -32.71M -27.86M -24.67M -22.16M -14.69M -10.48M -9.54M
EBIT
-30.98M -32.47M -27.58M -20.02M -16.21M -9.1M -5.09M -8.41M
Depreciation & Amortization
-3.8M -3.18M 627K 3.31M 3.23M 3.39M 3.56M 3.68M